|
TERF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.96953564568503E-13 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
8.154400E-01 |
| Stage1-vs-Stage3 |
1.778190E-02 |
| Stage1-vs-Stage4 |
3.785300E-04 |
| Stage2-vs-Stage3 |
1.764590E-01 |
| Stage2-vs-Stage4 |
3.366200E-02 |
| Stage3-vs-Stage4 |
2.458400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.04119998681307E-09 |
| Normal-vs-Asian |
1.68776104203516E-12 |
| Caucasian-vs-AfricanAmerican |
2.796400E-01 |
| Caucasian-vs-Asian |
3.831400E-01 |
| AfricanAmerican-vs-Asian |
7.229800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
1.754980E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
3.88240000037676E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.874600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.028760E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.097200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.332600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.959600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.607600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.020470E-04 |
| Classical-VS-Follicular |
9.991000E-01 |
| Classical-VS-Other |
3.555600E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.758770E-03 |
| Tall-VS-Other |
4.445600E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
4.547200E-01 |
| Follicular-VS-Normal |
1.62891922173003E-12 |
| Other-VS-Normal |
3.82119999997599E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
4.080200E-02 |
|
|
